Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  NASDAQ OMX COPENHAGEN  >  Novo Nordisk AS    NOVO B   DK0060534915

NOVO NORDISK AS

(NOVO B)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

Novo Nordisk : Gannett Fleming Inc. - Partnerships Forge Industrial Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
11/07/2019 | 10:35am EST

Gannett Fleming recently completed engineering and construction for the $40 million R. Steven Biggs Regional Wastewater Pretreatment Facility (WWPTF) in Clayton, North Carolina.

A ribbon-cutting ceremony on Oct. 10 celebrated the innovation and success of the state-of-the-art facility with community leaders and global health care company, Novo Nordisk.

Novo Nordisk selected Gannett Fleming to provide turnkey project delivery services for development of the 8-acre site. The team utilized a phased engineer-procure-construct (EPC) delivery approach to meet the 17-month schedule requirement in alignment with Novo Nordisk's new $2 billion Active Pharmaceutical Ingredient (API) manufacturing facility.

Services included design, permitting, procurement, and construction installation for multiple facilities, numerous treatment tanks, and solids handling and support equipment. The facility employs a fully automated process control system with various sensors integrated throughout. In addition, it features 100% equipment redundancy to protect against equipment failure and ensure optimal treatment to meet stringent wastewater discharge limits required in North Carolina.

'This pretreatment facility is a critical public infrastructure resource for growth in Clayton, Johnson County, and the region,' said David Broughton, Gannett Fleming project management director. 'With the ability to treat 450,000 gallons of waste per day and with more than 5.4 million gallons of total tank volume, the WWPTF not only meets the needs of Novo Nordisk but can be expanded to serve as a shared infrastructure asset to future industrial businesses in the region.'

Contact:

Tel: 717.763.7212

(C) 2019 Electronic News Publishing, source ENP Newswire

share with twitter share with LinkedIn share with facebook
share via e-mail
Latest news on NOVO NORDISK AS
04:21aNOVO NORDISK : Tour Du Rwanda 2020 - Teams Start Jetting in
AQ
02:08aNOVO NORDISK : Notice for the Annual General Meeting of Novo Nordisk A/S
PU
02:02aNotice for the Annual General Meeting of Novo Nordisk A/S
GL
02/17NOVO NORDISK : Share repurchase programme
AQ
02/17NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/14NOVO NORDISK : Disclosure of transaction data
PU
02/14NOVO NORDISK A/S : – Share repurchase programme
AQ
02/14TECHNICAL UNIVERSITY OF DENMARK - DT : Industrial Researcher Prize awarded to th..
AQ
02/14NOVO NORDISK : Trading in Novo Nordisk shares by board members, executives and a..
AQ
02/12BP Aims For Net Zero Carbon Emissions by 2050
DJ
More news
Financials (DKK)
Sales 2020 130 B
EBIT 2020 55 084 M
Net income 2020 42 184 M
Finance 2020 12 058 M
Yield 2020 2,08%
P/E ratio 2020 24,2x
P/E ratio 2021 21,4x
EV / Sales2020 7,83x
EV / Sales2021 7,36x
Capitalization 1 031 B
Chart NOVO NORDISK AS
Duration : Period :
Novo Nordisk AS Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends NOVO NORDISK AS
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 26
Average target price 411,44  DKK
Last Close Price 438,70  DKK
Spread / Highest target 11,7%
Spread / Average Target -6,21%
Spread / Lowest Target -49,2%
EPS Revisions
Managers
NameTitle
Lars Fruergaard Jørgensen President & Chief Executive Officer
Helge Lund Chairman
Maziar Mike Doustdar Executive Vice President-International Operations
Karsten Munk Knudsen Chief Financial Officer & Executive Vice President
Mads Krogsgaard Thomsen Chief Science Officer & Executive Vice President
Sector and Competitors
1st jan.Capitalization (M$)
NOVO NORDISK AS14.48%150 219
JOHNSON & JOHNSON2.10%390 914
ROCHE HOLDING AG10.08%298 571
NOVARTIS2.89%217 737
MERCK AND COMPANY-9.30%210 018
PFIZER-7.53%198 398